ABN AMRO Investment Solutions’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$968K Buy
11,245
+3,497
+45% +$307K 0.01% 526
2026
Q1
$701K Sell
7,748
-15,516
-67% -$1.42M 0.01% 517
2025
Q4
$2.09M Sell
23,264
-596
-2% -$56.5K 0.03% 316
2025
Q3
$2.35M Sell
23,860
-11,020
-32% -$1.09M 0.05% 240
2025
Q2
$3.18M Sell
34,880
-30,121
-46% -$2.91M 0.06% 212
2025
Q1
$7.36M Buy
65,001
+40,640
+167% +$4.35M 0.15% 117
2024
Q4
$2.57M Buy
24,361
+1,655
+7% +$178K 0.05% 230
2024
Q3
$2.45M Sell
22,706
-3,985
-15% -$435K 0.04% 241
2024
Q2
$2.9M Sell
26,691
-8,846
-25% -$1.04M 0.05% 210
2024
Q1
$4.69M Sell
35,537
-24,367
-41% -$3.04M 0.08% 172
2023
Q4
$7.29M Sell
59,904
-4,288
-7% -$478K 0.13% 138
2023
Q3
$7.2M Sell
64,192
-3,095
-5% -$393K 0.14% 135
2023
Q2
$9.8M Sell
67,287
-3,108
-4% -$422K 0.2% 109
2023
Q1
$9.1M Buy
+70,395
New +$8.84M 0.19% 117

Other funds holding ZBH

ABN AMRO Investment Solutions's ZBH Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its Zimmer Biomet (ZBH) stake by 45% in Q2 2026, buying an estimated $307K and bringing the position to 11,245 shares worth $968K. The position accounts for 0.01% of the portfolio, ranked #526.

ABN AMRO Investment Solutions first reported a position in ZBH in Q1 2023 and has held it in 14 quarters since. The position peaked at $9.8M in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • ABN AMRO Investment Solutions held 11,245 shares of Zimmer Biomet worth $968K as of Q2 2026.
  • ABN AMRO Investment Solutions bought 3,497 Zimmer Biomet shares in Q2 2026, an estimated $307K.
  • Zimmer Biomet made up 0.01% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #526 holding.
  • ABN AMRO Investment Solutions first reported a position in Zimmer Biomet in Q1 2023 and has held it in 14 quarters since.
  • ABN AMRO Investment Solutions's Zimmer Biomet position peaked at $9.8M in Q2 2023.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.